We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+3.07%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$2.44B
AUM Growth
+$94.2M
Cap. Flow
+$57.9M
Cap. Flow %
2.38%
Top 10 Hldgs %
24.38%
Holding
257
New
28
Increased
35
Reduced
38
Closed
30

Top Buys

Rank Stock Value
1
NLSN
Nielsen Holdings plc
NLSN
+$44M
2
APTV icon
Aptiv
APTV
+$28.3M
3
NTES icon
NetEase
NTES
+$26.1M
4
AGN
Allergan plc
AGN
+$19.3M
5
EWBC icon
East-West Bancorp
EWBC
+$18.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.51%
2 Communication Services 16.18%
3 Financials 14.99%
4 Consumer Discretionary 13.04%
5 Technology 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITUB icon
101
Itaú Unibanco
ITUB
$82.1B
$4.08M 0.17%
979,504
MNDT
102
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3.95M 0.16%
240,000
-60,000
-20% -$970K
SYF icon
103
Synchrony
SYF
$25.8B
$3.79M 0.16%
+150,000
New +$4.37M
MON
104
DELISTED
Monsanto Co
MON
$3.62M 0.15%
+35,000
New +$3.47M
CAH icon
105
Cardinal Health
CAH
$55B
$3.42M 0.14%
43,875
ALXN
106
DELISTED
Alexion Pharmaceuticals
ALXN
$3.35M 0.14%
28,735
+4,000
+16% +$568K
GGAL icon
107
Galicia Financial Group
GGAL
$7.12B
$3.15M 0.13%
103,000
LGF
108
DELISTED
Lions Gate Entertainment
LGF
$3.03M 0.12%
150,000
-70,000
-32% -$1.47M
HDB icon
109
HDFC Bank
HDB
$119B
$2.99M 0.12%
+180,000
New +$2.87M
BIIB icon
110
Biogen
BIIB
$30.7B
$2.42M 0.1%
10,030
-5,000
-33% -$1.32M
NEE icon
111
NextEra Energy
NEE
$178B
$2.2M 0.09%
67,520
-12,800
-16% -$384K
AYI icon
112
Acuity Brands
AYI
$10.8B
$1.96M 0.08%
7,900
+1,500
+23% +$375K
TSRO
113
DELISTED
TESARO, Inc.
TSRO
$1.93M 0.08%
23,000
VTAE
114
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$1.65M 0.07%
153,000
+20,000
+15% +$171K
NBIX icon
115
Neurocrine Biosciences
NBIX
$15.9B
$1.36M 0.06%
+30,000
New +$1.38M
FSLR icon
116
First Solar
FSLR
$24.4B
$1.36M 0.06%
28,000
BMRN icon
117
BioMarin Pharmaceuticals
BMRN
$13.7B
$1.28M 0.05%
16,500
-5,000
-23% -$425K
CI icon
118
Cigna
CI
$73.5B
$1.28M 0.05%
10,000
-14,000
-58% -$1.85M
JKS
119
JinkoSolar
JKS
$866M
$1.28M 0.05%
62,600
MRK icon
120
Merck
MRK
$330B
$1.23M 0.05%
22,386
ACAD icon
121
Acadia Pharmaceuticals
ACAD
$5.1B
$1.14M 0.05%
35,000
-7,000
-17% -$234K
TSLA icon
122
Tesla
TSLA
$1.29T
$1.06M 0.04%
75,000
WYNN icon
123
Wynn Resorts
WYNN
$10.7B
$1.04M 0.04%
+11,500
New +$1.09M
KYNB
124
Kyntra Bio
KYNB
$28.9M
$968K 0.04%
2,360
+560
+31% +$256K
CSIQ icon
125
Canadian Solar
CSIQ
$1.07B
$947K 0.04%
62,600

Similar funds

Handelsbanken Fonder's Q2 2016 Portfolio in Review

As of Q2 2016, Handelsbanken Fonder held 257 positions worth $2.44B, up 4% from $2.34B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Handelsbanken Fonder's Q2 2016 filing shows 28 new, 35 increased, 38 reduced and 30 closed positions. Its largest new stake was Nielsen Holdings plc: 834,000 shares worth $43.3M. The largest sale was Grupo Aeroportuario del Sureste, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Communication Services and Financials.

  • Handelsbanken Fonder's largest Q2 2016 buy was Nielsen Holdings plc: 834,000 shares worth $43.3M.
  • Handelsbanken Fonder added most to NetEase in Q2 2016, an estimated $26.1M increase.
  • Handelsbanken Fonder's biggest Q2 2016 reduction was Apple, cutting an estimated $29.8M.
  • Handelsbanken Fonder fully exited Grupo Aeroportuario del Sureste in Q2 2016, selling an estimated $46.5M.
  • Handelsbanken Fonder's ten largest holdings make up 24% of its $2.44B portfolio in Q2 2016.
  • Handelsbanken Fonder opened 28 new positions and closed 30 in Q2 2016.
  • Handelsbanken Fonder's portfolio value rose 4% quarter-over-quarter to $2.44B.

Based on Handelsbanken Fonder's 13F filing for Q2 2016, filed 15 Jul 2016.